Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1998
12/08/1998CA2053209C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
12/03/1998WO1998054365A1 Control of immune responses by modulating activity of glycosyltransferases
12/03/1998WO1998054311A1 Zinc finger protein derivatives and methods therefor
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054215A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
12/03/1998WO1998054190A1 Novel compounds
12/03/1998WO1998054185A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo[3,2-d]pyrimidin-4-ones
12/03/1998WO1998054170A1 SUBSTITUTED 2-(2,6-DIOXOPIPERIDIN-3-YL)-PHTHALIMIDES AND 1-OXOISOINDOLINES AND METHOD OF REDUCING TNFα LEVELS
12/03/1998WO1998054093A1 Novel angiogenesis inhibitors
12/03/1998WO1998053846A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
12/03/1998WO1998053845A1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053821A1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-β1
12/03/1998WO1998053818A1 Sulfonamides as cell adhesion inhibitors
12/03/1998WO1998053814A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998WO1998053806A1 Medicinal compositions for topical administration containing vitamin d and vitamin k
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291778A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/03/1998CA2291709A1 Novel angiogenesis inhibitors
12/03/1998CA2291708A1 Sulfonamides as cell adhesion inhibitors
12/03/1998CA2288971A1 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
12/03/1998CA2288317A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo¬3,2-d|pyrimidin-4-ones
12/02/1998EP0881298A2 Metalloporoteases
12/02/1998EP0881292A2 Streptocococcus pneumoniae peptide release factor
12/02/1998EP0881289A2 Novel 7TM receptor (H2CAA71)
12/02/1998EP0880970A1 Pharmaceutical compositions comprising an anticytokine
12/02/1998EP0880701A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression
12/02/1998EP0880597A1 THERAPEUTIC APPLICATIONS FOR THE ANTI-T-BAM (CD40-L) MONOCLONAL ANTIBODY 5c8
12/02/1998EP0880586A1 Lyst1 and lyst2 gene compositions and methods of use
12/02/1998EP0880526A1 Heterocycle-condensed morphinoid derivatives (ii)
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880523A1 Pyrazolopyrimidines as crf receptor antagonists
12/02/1998EP0880519A1 Thiazolylbenzofuran derivatives and pharmaceutical compositions containing them
12/02/1998EP0880363A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0880350A1 Multiple sclerosis treatment
12/02/1998EP0691986B1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
12/02/1998CN1200737A Recombinant anti-CD4 antibodies for human therapy
12/02/1998CN1200673A Eye drops
12/02/1998CN1040982C Method for preparing pyranoquinoline and salts thereof
12/02/1998CN1040980C Second messenger cell signaling inhibitors
12/02/1998CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene
12/01/1998US5844094 Target binding polypeptide
12/01/1998US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto
12/01/1998US5844004 10-substituted 1,8-dihydroxy-9 (10H) anthracenone pharmaceuticals
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843986 Tricyclic amide compounds
12/01/1998US5843968 Symmetrical bis-heteroarylmethoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis
12/01/1998US5843936 Topical administration of azaspiranes to prevent or treat skin conditions associated with hyperproliferation of keratinocytes
12/01/1998US5843913 Nucleic acid respiratory syncytial virus vaccines
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843886 Method of treating or preventing Type 1 diabetes by oral administration of insulin
12/01/1998US5843885 ICAM-1/LFA-1 short-chain peptides and method of using same
12/01/1998US5843687 Isolated, tyrosinase derived peptides and uses thereof
12/01/1998US5843672 Allergenic proteins and peptides from dog dander and uses therefor
12/01/1998US5843456 Alvac poxvirus-rabies compositions and combination compositions and uses
12/01/1998US5843449 Proteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseases
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998CA2016089C Salts of azelastine having improved solubility
11/1998
11/30/1998CA2233554A1 Novel compounds
11/29/1998CA2233561A1 Novel compounds
11/26/1998WO1998053079A1 Ubiquitin conjugation proteins
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052951A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052942A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052933A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998WO1998052929A1 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof
11/26/1998WO1998052915A2 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998WO1998052914A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998WO1998052608A1 Green porphyrins as immunomodulators
11/26/1998WO1998052606A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998WO1998052582A2 Non-myeloablative tolerogenic treatment
11/26/1998WO1998052573A1 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/26/1998WO1998052571A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052570A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998WO1998052558A1 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
11/26/1998WO1998041539A3 Secreted proteins and polynucleotides encoding them
11/26/1998WO1998030582A3 Secreted proteins and polynucleotides encoding them
11/26/1998DE19722848A1 Leukotrien-B¶4¶-Derivate, insbesondere Oximo-LTB¶4¶-Antagonisten Leukotriene B¶4¶ derivatives, in particular oximo-LTB¶4¶ antagonists
11/26/1998DE19721099A1 Verwendung von Fumarsäurederivaten Use of fumaric acid derivatives
11/26/1998CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis
11/26/1998CA2291156A1 Use of a cd40:cd154 binding interruptor to prevent counter adaptive immune responses, particularly graft rejection
11/26/1998CA2291123A1 Leukotriene b4 derivatives, in particular oximo-ltb4 antagonists
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2291112A1 Leukotriene b4 derivatives, in particular 7-methylcyclohexyl-ltb4 antagonists
11/26/1998CA2291111A1 Quinoline-4-carboxamide derivatives as nk-2 and nk-3 receptor antagonists
11/26/1998CA2290769A1 Ubiquitin conjugation proteins
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2290367A1 Non-myeloablative tolerogenic treatment
11/26/1998CA2289655A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289654A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89
11/26/1998CA2289441A1 Green porphyrins as immunomodulators
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
1 ... 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 ... 1172